余 文良

Medicine & Life Sciences

1. Klebsiella pneumoniae 100%
2. Bacteremia 42%
3. Tigecycline 39%
4. Serratia marcescens 37%
5. Enterobacter cloacae 33%
6. Colistin 29%
7. Cefotaxime 28%
8. Ceftazidime 28%
9. Imipenem 24%
10. Coronavirus 23%
11. Carbapenems 22%
12. Genes 22%
13. Critical Illness 21%
14. Intensive Care Units 21%
15. Infections 20%
16. In Vitro Techniques 18%
17. Cefepime 18%
18. Phenotype 18%
19. Ceftriaxone 17%
20. Meropenem 17%
21. Ciprofloxacin 17%
22. Molecular Epidemiology 16%
23. Mortality 16%
24. Pneumonia 15%
25. Abscess 15%
26. Cytomegalovirus 15%
27. Cytomegalovirus Infections 15%
28. Human Influenza 15%
29. Aspergillosis 15%
30. Cephalosporins 14%
31. carbapenemase 14%
32. Coinfection 14%
33. Amikacin 13%
34. Virulence 13%
35. Therapeutics 13%
36. Liver Abscess 13%
37. Microbial Sensitivity Tests 12%
38. Fever 11%
39. Gentamicins 11%
40. Plasmids 11%
41. Sulbactam 11%
42. Enterobacteriaceae 11%
43. Serogroup 10%
44. beta-Lactamases 10%
45. Cephalosporinase 10%
46. Pyogenic Liver Abscess 10%
47. Methicillin-Resistant Staphylococcus aureus 10%
48. Anti-Bacterial Agents 10%
49. Isoelectric Focusing 9%